0000950170-24-070563.txt : 20240607
0000950170-24-070563.hdr.sgml : 20240607
20240607160008
ACCESSION NUMBER: 0000950170-24-070563
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Michael J
CENTRAL INDEX KEY: 0001589232
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 241029129
MAIL ADDRESS:
STREET 1: C/O PARK CITY CAPITAL, LLC
STREET 2: 100 CRESCENT COURT SUITE 700
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
ownership.xml
4
X0508
4
2024-06-05
false
0001645460
Cue Biopharma, Inc.
CUE
0001589232
Fox Michael J
C/O CUE BIOPHARMA, INC.
40 GUEST STREET
BOSTON
MA
02135
true
false
false
false
false
Stock Option (right to buy)
1.65
2024-06-05
4
A
false
48800
0.0
A
2034-06-04
Common Stock
48800
48800
D
Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy.
This option was granted on June 5, 2024. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments
/s/ Michael J. Fox by Colin Sandercock, attorney-in-fact
2024-06-07